Coughlin Rainboth Murphy & Lown Files One of the Nation’s First Fentanyl Spray (Subsys) Cases

Attorney Michael Rainboth of Coughlin Rainboth Murphy & Lown has filed one of the first lawsuits in the country against Insys Therapeutics, Inc.

If you or someone you know has been prescribed the powerful narcotic Subsys, also known as oral Fentanyl spray, call us now at 603-431-1993.

Subsys is a medication that is 100 times more potent than morphine.  It is a fentanyl-based opioid mouth spray intended to treat cancer patients suffering intense episodes of breakthrough cancer pain.  Subsys should not be prescribed to patients who do not have cancer, however, many doctors have been found to be prescribing it to patients off-label, who do not have cancer.

Insys Therapeutics, Inc., the drug’s manufacturer, is currently being investigated by the FBI and the Department of Justice for allegations that it bribed doctors to unnecessarily prescribe Subsys to patients who did not have cancer.

On December 8, 2016 the Department of Justice arrested six of Insys’ top former corporate executives, including Insys’ former CEO and President on charges and allegations that they led a nationwide conspiracy to bribe doctors to unnecessarily prescribe Subsys off-label to patients who did not have cancer. Download the Indictment here.

Coughlin Rainboth Murphy & Lown has already filed one lawsuit against the manufacturers of Subsys.  We are investigating additional pharmaceutical suits.

The inappropriate use of Fentanyl-based sprays like Subsys can have serious consequences on individuals and families, including addiction, hospitalization, and death.  If you or someone you know has been prescribed Subsys, CONTACT US TODAY at 603-431-1993.

If you were prescribed Subsys by Dr. O’Connell’s PainCare clinic, CALL US NOW AT 603-431-1993.  You may be entitled to compensation.